Cadrenal Therapeutics, Inc. (CVKD) Tops Q1 EPS by 31c
Tweet
Share
E-mailGet Alerts CVKD Hot Sheet
Join SI Premium – FREE
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) reported Q1 EPS of ($1.04), $0.31 better than the analyst estimate of ($1.35).
For earnings history and earnings-related data on Cadrenal Therapeutics, Inc. (CVKD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- MSC Industrial (MSM) PT Raised to $130 at Jefferies
- AeroVironment wins $500M defense contract
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
